514 related articles for article (PubMed ID: 17630397)
21. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women.
Burger HG; Cahir N; Robertson DM; Groome NP; Dudley E; Green A; Dennerstein L
Clin Endocrinol (Oxf); 1998 Jun; 48(6):809-13. PubMed ID: 9713572
[TBL] [Abstract][Full Text] [Related]
22. Hormonal changes in the menopause transition.
Burger HG; Dudley EC; Robertson DM; Dennerstein L
Recent Prog Horm Res; 2002; 57():257-75. PubMed ID: 12017547
[TBL] [Abstract][Full Text] [Related]
23. Association of physical activity with reproductive hormones: the Penn Ovarian Aging Study.
Schmitz KH; Lin H; Sammel MD; Gracia CR; Nelson DB; Kapoor S; DeBlasis TL; Freeman EW
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2042-7. PubMed ID: 17905944
[TBL] [Abstract][Full Text] [Related]
24. The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition.
Randolph JF; Crawford S; Dennerstein L; Cain K; Harlow SD; Little R; Mitchell ES; Nan B; Taffe J; Yosef M
J Clin Endocrinol Metab; 2006 Aug; 91(8):3034-40. PubMed ID: 16720656
[TBL] [Abstract][Full Text] [Related]
25. The influence of physiological and surgical menopause on coronary heart disease risk markers.
Verhoeven MO; van der Mooren MJ; Teerlink T; Verheijen RH; Scheffer PG; Kenemans P
Menopause; 2009; 16(1):37-49. PubMed ID: 18791484
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of ovarian reserve testing.
Steiner AZ
Obstet Gynecol Surv; 2009 Feb; 64(2):120-8. PubMed ID: 19159496
[TBL] [Abstract][Full Text] [Related]
27. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.
Burger HG; Dudley EC; Hopper JL; Groome N; Guthrie JR; Green A; Dennerstein L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4025-30. PubMed ID: 10566644
[TBL] [Abstract][Full Text] [Related]
28. Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause.
Hale GE; Burger HG
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):7-23. PubMed ID: 19046657
[TBL] [Abstract][Full Text] [Related]
29. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging.
Harlow SD; Crawford S; Dennerstein L; Burger HG; Mitchell ES; Sowers MF;
Climacteric; 2007 Apr; 10(2):112-9. PubMed ID: 17453859
[TBL] [Abstract][Full Text] [Related]
30. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.
Sowers MR; Eyvazzadeh AD; McConnell D; Yosef M; Jannausch ML; Zhang D; Harlow S; Randolph JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3478-83. PubMed ID: 18593767
[TBL] [Abstract][Full Text] [Related]
31. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
[TBL] [Abstract][Full Text] [Related]
32. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.
Knauff EA; Richardus R; Eijkemans MJ; Broekmans FJ; de Jong FJ; Fauser BC; Bosch AM
Reprod Sci; 2007 Dec; 14(8):780-5. PubMed ID: 18089596
[TBL] [Abstract][Full Text] [Related]
33. Symptoms in the menopausal transition: hormone and behavioral correlates.
Freeman EW; Sammel MD; Lin H; Gracia CR; Kapoor S
Obstet Gynecol; 2008 Jan; 111(1):127-36. PubMed ID: 18165401
[TBL] [Abstract][Full Text] [Related]
34. The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls.
de Koning CH; McDonnell J; Themmen AP; de Jong FH; Homburg R; Lambalk CB
Hum Reprod; 2008 Jun; 23(6):1416-23. PubMed ID: 18375407
[TBL] [Abstract][Full Text] [Related]
35. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
Guthrie JR; Dennerstein L; Hopper JL; Burger HG
Obstet Gynecol; 1996 Sep; 88(3):437-42. PubMed ID: 8752255
[TBL] [Abstract][Full Text] [Related]
36. Anti-Mullerian hormone in premenopausal women and after spontaneous or surgically induced menopause.
La Marca A; De Leo V; Giulini S; Orvieto R; Malmusi S; Giannella L; Volpe A
J Soc Gynecol Investig; 2005 Oct; 12(7):545-8. PubMed ID: 16046154
[TBL] [Abstract][Full Text] [Related]
37. Symptoms associated with menopausal transition and reproductive hormones in midlife women.
Freeman EW; Sammel MD; Lin H; Gracia CR; Pien GW; Nelson DB; Sheng L
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):230-40. PubMed ID: 17666595
[TBL] [Abstract][Full Text] [Related]
38. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
[TBL] [Abstract][Full Text] [Related]
39. Menstrual bleeding, hormones, and the menopausal transition.
Johannes CB; Crawford SL
Semin Reprod Endocrinol; 1999; 17(4):299-309. PubMed ID: 10851570
[TBL] [Abstract][Full Text] [Related]
40. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
